1. Home
  2. GTY vs ORKA Comparison

GTY vs ORKA Comparison

Compare GTY & ORKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Getty Realty Corporation

GTY

Getty Realty Corporation

HOLD

Current Price

$28.07

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Logo Oruka Therapeutics Inc.

ORKA

Oruka Therapeutics Inc.

HOLD

Current Price

$31.70

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTY
ORKA
Founded
1955
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GTY
ORKA
Price
$28.07
$31.70
Analyst Decision
Buy
Strong Buy
Analyst Count
5
10
Target Price
$31.80
$48.20
AVG Volume (30 Days)
370.6K
440.6K
Earning Date
10-22-2025
11-12-2025
Dividend Yield
6.83%
N/A
EPS Growth
10.25
N/A
EPS
1.28
N/A
Revenue
$214,194,000.00
N/A
Revenue This Year
$6.23
N/A
Revenue Next Year
$8.82
N/A
P/E Ratio
$22.24
N/A
Revenue Growth
8.17
N/A
52 Week Low
$25.39
$5.49
52 Week High
$32.50
$32.28

Technical Indicators

Market Signals
Indicator
GTY
ORKA
Relative Strength Index (RSI) 48.53 60.77
Support Level $28.31 $27.84
Resistance Level $28.79 $31.35
Average True Range (ATR) 0.43 1.96
MACD -0.03 -0.21
Stochastic Oscillator 38.10 89.55

Price Performance

Historical Comparison
GTY
ORKA

About GTY Getty Realty Corporation

Getty Realty Corp is the real estate investment trust in the U.S. specializing in the acquisition, financing, and development of convenience, automotive, and other single tenant retail real estate. The company's portfolio includes convenience stores, car washes, automotive service centers (gasoline and repair, oil and maintenance, tire and battery, collision), automotive parts retailers, and certain other freestanding retail properties, including drive-thru quick service restaurants. It generates majority of the revenue in the form of rental income.

About ORKA Oruka Therapeutics Inc.

Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.

Share on Social Networks: